您的位置: 首页 > 农业专利 > 详情页

Compositions, devices and methods of use thereof for the treatment of cancers
专利权人:
Inc.;Intarcia Therapeutics
发明人:
Karling Alice Leung
申请号:
US15597788
公开号:
US10159714B2
申请日:
2017.05.17
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The use of GLP-1 receptor agonists, such as glucagon-like peptide-1 (GLP-1) or exenatide, for the treatment of cancer is described. The GLP-1 receptor agonists are typically delivered using an implanted osmotic delivery device that provides for continuous delivery of the GLP-1 receptor agonist for at least one month. Additional beneficial agents, such as anticancer agents, can also be administered.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充